Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult Participants.
Saved in:
| Title: | Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult Participants. |
|---|---|
| Authors: | Zhu T; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA., Pawlak S; Pfizer Clinical Research Unit, New Haven, Connecticut, USA., Toussi SS; Pfizer Worldwide Research, Development and Medical, Pearl River, New York, USA., Hackman F; Pfizer Worldwide Research, Development and Medical, Cambridge, UK., Thompson K; Pfizer Clinical Research Unit, New Haven, Connecticut, USA., Song W; Pfizer Worldwide Research, Development and Medical, Groton, Connecticut, USA., Salageanu J; Pfizer Global Product Development, Groton, Connecticut, USA., Winter E; Pfizer Global Product Development, Groton, Connecticut, USA., Shi H; Pfizer Global Product Development, Groton, Connecticut, USA., Winton J; Pfizer Global Product Development, Groton, Connecticut, USA., Binks M; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Dec; Vol. 11 (12), pp. 1382-1393. Date of Electronic Publication: 2022 Oct 26. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160-7648 |
|---|---|
| DOI: | 10.1002/cpdd.1174 |
